Sign up today to learn more about Impossible Foods stock
EquityZen is a marketplace for shares of proven pre IPO tech companies
Impossible Foods Stock
Plant-Based Meat Alternatives
About Impossible Foods Stock
Impossible Foods, Inc. develops plant-based substitutes for meat and dairy products. According to the company, it observes animal products at the molecular level and selects specific proteins and nutrients from greens, seeds, and grains to recreate meats and dairy products. The company's flagship product is the Impossible Burger, which they claim is made from ingredients including plant-based protein, coconut oil, and heme, among other ingredients. In January 2019, the company unveiled the Impossible Burger 2.0, which swaps out whey protein for soy protein. Heme is a protein found in animal muscle and is, according to the company, responsible for the characteristic taste and aroma of meat. Impossible Foods makes heme from plants.
The company was incorporated in 2011 and is based in Redwood City, California. Notable investors in Impossible Foods include Temasek, Bill Gates, GV, Khosla Ventures, and Li Ka-Shing.
Investors
G Squared
Impossible Foods, Indigo, 23andMe, Fair, Collective Health, Postmates, Blend, Getaround, Tipalti, Thumbtack
GV
Uber, Robinhood, Jet, Impossible Foods, Slack, SambaNova Systems, Snyk, DocuSign, Olive, Cloudera
Horizons Ventures
Impossible Foods, Scopely, Eat Just, Improbable, Airwallex, Hippo Insurance, Blockstream, States Title, wefox Group, BitPay
Innovative Fund
Khosla Ventures
Instacart, Stripe, DoorDash, Impossible Foods, Palantir Technologies, View, Zenefits, Opendoor, Faire, Oscar Health
Microsoft
Flipkart, Databricks, Impossible Foods, Pivotal, ConsenSys, Adaptive Biotechnologies, ClearMotion, D2iQ, SnapLogic, Foursquare
Sailing Capital
Serena Ventures
Temasek Holdings
PharmEasy, Tokopedia, DoorDash, Impossible Foods, Wish, AvidXchange, SambaNova Systems, Snyk, Farmers Business Network, ConsenSys
Trinity Capital Investment
Viking Global Investors
Impossible Foods, Moderna Therapeutics, Apeel Sciences, Adaptive Biotechnologies, Arctic Wolf, Talkdesk, Druva, Color, Clip, Iterable
Funding History
| September 2011 | $6.4M |
|---|---|
| February 2013 | $3.1M |
| July 2013 | $27.6M |
| June 2014 | $41.1M |
| August 2015 | $125M |
| May 2019 | $774M |
| May 2019 | $201M |
| March 2020 | $297M |
| March 2020 | $203M |
| August 2020 | $191M |
| August 2020 | $9.5M |
| November 2021 | $457M |
| November 2021 | $43.5M |
Management
Chief Executive Officer
Peter McGuinness
Chief Financial Officer
David Borecky
Press
TechCrunch - Jan, 7 2020
mercurynews - Jan, 7 2020
Forbes - Feb, 25 2020
Forbes - Mar, 16 2020
Vegconomist - Apr, 18 2020
Yahoo Finance! - Apr, 22 2020
Fox Business - Apr, 21 2020
financialpost - Oct, 26 2020
dlvr - Oct, 23 2020
foodbusinessnews - Dec, 8 2020
TechCrunch - Aug, 13 2020
TechCrunch - Jul, 30 2020
appleinsider - Apr, 12 2021
webpronews - Apr, 9 2021
businesswire - Feb, 19 2021
foodsafetynews - Feb, 4 2021
reut - Feb, 2 2021
finance - Jan, 6 2021
engt - May, 8 2021
agfundernews - May, 6 2021
thespoon - Jul, 16 2021
agfundernews - Jun, 25 2021
trib - May, 7 2021
prlog - Jul, 26 2021
finance - Aug, 13 2021
foodbusinessnews - Aug, 9 2021
bayareane - Dec, 9 2021
on - Dec, 8 2021
techstartups - Nov, 23 2021
vulcanpost - Nov, 18 2021
finance - Nov, 16 2021
bit - Nov, 16 2021
agfundernews - Mar, 17 2022
nzherald - Mar, 13 2022
cnbc - Mar, 4 2022
vegconomist - Mar, 1 2022
bayareane - Jan, 24 2022
foodbusinessnews - Apr, 21 2022
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
